-
Dr. Wu Yilong, Dr. Cheng Ying, and Dr.Han Baohui Discuss the latest advancements in Small Cell Lung Cancer Research and Analyze the Development of ADC
For the first time in three years, Chinese experts were able to participated in the WCLC conference in person, following the end of the impact of the COVID-19 pandemic , engaging in face-to-face discussions with international scholars. Dr. Wu Yilong, Dr. Cheng Ying, and Dr. Han Baohui shared their experiences of attending the conference in…
-
ESMO Highlights | Professor Wei Yu’s Commentary on Advances in Neoadjuvant Therapy and Bladder Preservation in Bladder Cancer
Editor’s Note: Bladder cancer is a common tumor in the urinary system, with muscle-invasive bladder cancer (MIBC) accounting for approximately 20% of all bladder cancers. Nearly half of non-muscle-invasive bladder…
-
ESMO in Five Minutes | Prof. Haitao Zhao : Highlights of Advances in the Treatment of Cholangiocarcinoma
95MO: Efficacy of Tinengotinib in Treating Advanced Fibroblast Growth Factor Receptor (FGFR) Inhibitor Resistant/Recurrent Cholangiocarcinoma Patients Background Fibroblast Growth Factor Receptor inhibitors (FGFRi) have been shown to play a role…
-
ESMO 2023丨Professor Zhimin Shao: monarcE Study 5-Year Follow-Up Data Revealed, Sustained Benefit for Patients
Editor’s Note: The monarchE study is a randomized, open-label, multicenter Phase III clinical trial designed to compare the efficacy and safety of abemaciclib combined with endocrine therapy versus endocrine therapy…
-
Dr. Jie Jin: the New JAK Inhibitor Jaktinib in the Treatment of Myelofibrosis (MF)
The 28th European Hematology Association (EHA) Congress was held from June 8th to June 11th, 2023, in Frankfurt, Germany, in a hybrid format combining online and offline meetings. As the largest international conference in the field of European hematology, the EHA Congress covered a wide range of scientific topics, clinical and basic research, including both…
-
The Mysteries of Hepatitis D: Key Molecular Determinants in Virus Replication and Assembly
Dr. Wenshi Wang is the Principal Investigator of the hepatitis virus research group, Xuzhou Medical University, China. He obtained his Ph.D. from Erasmus University Rotterdam, the Netherlands, and completed post-doc research training at Heidelberg University, Germany in the field of hepatitis viruses. He has contributed more than 50 peer-reviewed publications, with 20 first or corresponding…
-
ESMO 2023 | Professor Feng Jin: Less is More – New Evidence Added to Surgery Exemption After Neoadjuvant Therapy for Breast Cancer
Editor’s Note: The European Society for Medical Oncology (ESMO), as a globally renowned academic conference in the field of oncology, announces numerous cutting-edge developments each year. The ESMO 2023 annual…
-
ESMO Hot Topic: Success Imminent in MATTERHORN Phase III Study, Neoadjuvant Durvalumab Shows Promising Progress for Gastric Cancer pCR
Editor’s Note: The 2023 ESMO Annual Meeting took place from October 20th to 24th in Madrid, Spain. As a highly authoritative annual event in the field of oncology, it unveils…
Connecting Medical Expertise through Media